Screening compound: C25H29N3O4 (L610-0354)

Screening compound: C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> (L610-0354)
Screening compound: C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> (L610-0354) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C25H29N3O4 (L610-0354)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L610-0354

Molecular Formula

C25H29N3O4 (C25 H29 N3 O4)

Compound Name

2-{[5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]methyl}-N-(3-ethoxypropyl)benzamide

IUPAC name

2-({28-dioxo-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-trien-9-yl}methyl)-N-(3-ethoxypropyl)benzamide

SMILES

CCOCCCNC(c1c(CN(c(cccc2)c2C(N2C3CCC2)=O)C3=O)cccc1)=O

InChI

InChI=1S/C25H29N3O4/c1-2-32-16-8-14-26-23(29)19-10-4-3-9-18(19)17-28-21-12-6-5-11-20(21)24(30)27-15-7-13-22(27)25(28)31/h3-6,9-12,22H,2,7-8,13-17H2,1H3,(H,26,29)/t22-/m0/s1

InChI Key

IJMWBPDSPDTYSR-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27465868

C25H29N3O4 (L610-0354) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Proteases
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with C25H29N3O4 (L610-0354) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C25H29N3O4 (L610-0354)?
Check Price and Availability of C25H29N3O4 (L610-0354), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C25H29N3O4 (L610-0354) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C25H29N3O4 (L610-0354)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C25H29N3O4 (L610-0354)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C25H29N3O4 (L610-0354) available by request